An Unsupervised Approach to Identify Molecular Phenotypic Components Influencing Breast Cancer Features

To discover a biological basis for clinical subgroupings within breast cancers, we applied principal components (PCs) analysis to cDNA microarray data from 36 breast cancers. We correlated the resulting PCs with clinical features. The 35 PCs discovered were ranked in order of their impact on gene expression patterns. Interestingly, PC 7 identified a unique subgroup consisting of estrogen receptor (ER); (+) African-American patients. This group exhibited global molecular phenotypes significantly different from both ER (−) African-American women and ER (+) or ER (−) Caucasian women (P < 0.001). Additional significant PCs included PC 4, correlating with lymph node metastasis (P = 0.04), and PC 10, with tumor stage (stage 2 versus stage 3; P = 0.007). These results provide a molecular phenotypic basis for the existence of a biologically unique subgroup comprising ER (+) breast cancers from African-American patients. Moreover, these findings illustrate the potential of PCs analysis to detect molecular phenotypic bases for relevant clinical or biological features of human tumors in general.

[1]  M J O'Hare,et al.  Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.

[2]  G. Colditz,et al.  African‐American ethnicity, socioeconomic status, and breast cancer survival , 2002, Cancer.

[3]  M. West,et al.  Racial differences in breast carcinoma survival , 2000, Cancer.

[4]  O. Kallioniemi,et al.  From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome. , 2001, Seminars in cancer biology.

[5]  Joshua M. Stuart,et al.  MICROARRAY EXPERIMENTS : APPLICATION TO SPORULATION TIME SERIES , 1999 .

[6]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[7]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Rochefort,et al.  Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Noam Harpaz,et al.  Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. , 2002, Gastroenterology.

[10]  B. Wójcik,et al.  Breast carcinoma survival analysis for african american and white women in an equal‐access health care system , 1998, Cancer.

[11]  L. Bernstein,et al.  Ethnicity‐related variation in breast cancer risk factors , 2003, Cancer.

[12]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[13]  R. Royak-Schaler,et al.  Tumor biology and prognosis in black breast cancer patients: a review. , 2001, Cancer detection and prevention.

[14]  K. Malone,et al.  Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  Sam Kash Kachigan.  Multivariate statistical analysis: A conceptual introduction , 1982 .

[16]  D. Shibata,et al.  Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays , 2002, Oncogene.

[17]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[18]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Sato,et al.  Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon , 2002, Oncogene.

[20]  D. Heitjan,et al.  Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer. , 2001, Anticancer research.

[21]  M. Jackson,et al.  Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.

[22]  S. Zurrida,et al.  Breast cancer: a practical guide , 2005 .

[23]  P. Athanassiadou,et al.  DNA Topoisomerase II-Alpha Immunoreactivity as a Marker of Tumor Aggressiveness in Invasive Breast Cancer , 2000, Pathobiology.

[24]  S. Singletary,et al.  Effects of race and socioeconomic status on survival of 1,332 black, hispanic, and white women with breast cancer , 1997, Annals of Surgical Oncology.

[25]  S. Sukumar,et al.  Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer , 2001, Oncogene.

[26]  F. Révillion,et al.  Proteomic analysis reveals that 14-3-3σ is down-regulated in human breast cancer cells , 2001 .

[27]  Jing Yin,et al.  Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. , 2002, Cancer research.

[28]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[29]  R. Severson,et al.  Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. , 1997, American journal of obstetrics and gynecology.

[30]  L. Yamamoto,et al.  Estrogen and progesterone receptor mrna levels in primary breast cancer: Association with patient survival and other clinical and tumor features , 1994, International journal of cancer.

[31]  L. Calvocoressi,et al.  Mammography screening in African American women , 2003 .

[32]  W. Cleveland.  Robust Locally Weighted Regression and Smoothing Scatterplots , 1979 .

[33]  O. Olopade,et al.  Breast cancer genetics in African Americans , 2003, Cancer.

[34]  L. Newman,et al.  Overview of the summit meeting evaluating research in African‐American women , 2003, Cancer.

[35]  G. Lyman,et al.  Importance of race on breast cancer survival , 2006, Annals of Surgical Oncology.

[36]  R. Clarke,et al.  Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women , 2002, Cancer.

[37]  Carsten O. Peterson,et al.  Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. , 2001, Cancer research.

[38]  M. Widschwendter,et al.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.

[39]  W. Wurst,et al.  Permutation-validated principal components analysis of microarray data , 2002, Genome Biology.

[40]  J. Britton,et al.  Environmental risk factors for breast cancer among African‐American women , 2003, Cancer.